Novavax (NVAX) Other Non-Current Liabilities (2010 - 2026)
Novavax (NVAX) reported Other Non-Current Liabilities of $165.74 million for Q2 2026, down 42.4% from $287.59 million a year earlier and down 14.2% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax posted Other Non-Current Liabilities of $239.07 million, down 33.5% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 77.7% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $359.61 million in FY2024 (+985.5%), $33.13 million in FY2023 (-40.5%), $55.7 million in FY2022 (+32.2%) and $42.12 million in FY2021 (+212.5%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q4 2023.
- Year over year, Other Non-Current Liabilities has now declined in each of the last six quarters, with growth averaging 198.0% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2024 (growth of 985.5%); the low point was Q3 2023 (a decline of 62.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $193.24 million (Q1 2026), $239.07 million (Q4 2025) and $263.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.74 Mn |
| Mar 31, 2026 | 193.24 Mn |
| Dec 31, 2025 | 239.07 Mn |
| Sep 30, 2025 | 263.48 Mn |
| Jun 30, 2025 | 287.59 Mn |
| Mar 31, 2025 | 313.73 Mn |
| Dec 31, 2024 | 359.61 Mn |
| Sep 30, 2024 | 318.92 Mn |
| Jun 30, 2024 | 335.29 Mn |
| Mar 31, 2024 | 351.72 Mn |
| Dec 31, 2023 | 33.13 Mn |
| Sep 30, 2023 | 37.30 Mn |
| Jun 30, 2023 | 38.38 Mn |
| Mar 31, 2023 | 47.51 Mn |
| Dec 31, 2022 | 55.70 Mn |
| Sep 30, 2022 | 98.57 Mn |
| Jun 30, 2022 | 69.08 Mn |
| Mar 31, 2022 | 66.80 Mn |
| Dec 31, 2021 | 42.12 Mn |
| Sep 30, 2021 | 28.09 Mn |
API Access
Novavax Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();